Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years

Lun Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1936-3971; OpenAlex author ID A5100661416. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
34
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 6 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 2 papers

Papers 14

  1. HSPB1/KDM1 A facilitates ANXA2 expression via hypomethylated DNA promoter to inhibit ferroptosis and enhance gemcitabine resistance in pancreatic cancer. Last author DOI 10.1007/s00210-025-04228-2↗
  2. LARP4B inhibits ferroptosis and accelerates the progression of pancreatic cancer by activating WNK1-induced NRF2/GCH1/BH4 pathway. First author DOI 10.1093/intbio/zyaf019↗
  3. Myoglobin improves doxycycline sensitivity in pancreatic cancer through promoting heme oxygenase-1-mediated ferroptosis. Co-author DOI 10.1002/tox.24078↗
  4. Exosomal HSPB1, interacting with FUS protein, suppresses hypoxia-induced ferroptosis in pancreatic cancer by stabilizing Nrf2 mRNA and repressing P450. Co-author DOI 10.1111/jcmm.18209↗
  5. High‑glucose microenvironment promotes perineural invasion of pancreatic cancer via activation of hypoxia inducible factor 1α. Co-author DOI 10.3892/or.2022.8275↗
  6. Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer. Co-author DOI 10.1155/2016/1616781↗
  7. The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species. Co-author DOI 10.1155/2016/3897250↗
  8. Hyperglycemia Promotes the Epithelial-Mesenchymal Transition of Pancreatic Cancer via Hydrogen Peroxide. First author DOI 10.1155/2016/5190314↗
  9. Lipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer. Co-author DOI 10.1155/2016/6815727↗
  10. Pancreatic stellate cells contribute pancreatic cancer pain via activation of sHH signaling pathway. Co-author DOI 10.18632/oncotarget.7776↗
  11. Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway. Co-author DOI 10.3892/or.2016.5044↗
  12. Resveratrol in the treatment of pancreatic cancer. Co-author DOI 10.1111/nyas.12837↗
  13. Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer. Co-author DOI 10.18632/oncotarget.3069↗
  14. Aspirin: a potential therapeutic approach in pancreatic cancer. Co-author DOI 10.2174/09298673113209990196↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liuxu Yang · 3 shared papers, 2024–2025 · strength 1.10
  2. Keyuan Du · 2 shared papers, 2024 · strength 0.67
  3. Jiehao Tu · 1 shared paper, 2025 · strength 0.54
  4. Qingyong Ma · 8 shared papers, 2013–2016 · strength 0.39
  5. Yixuan Yang · 1 shared paper, 2024 · strength 0.31
  6. Liang Zong · 6 shared papers, 2015–2016 · strength 0.31
  7. Wei Li · 5 shared papers, 2016 · strength 0.30
  8. Xuqi Li · 6 shared papers, 2015–2016 · strength 0.29
  9. Qinhong Xu · 6 shared papers, 2013–2016 · strength 0.27
  10. Jianjun Lei · 5 shared papers, 2015–2016 · strength 0.23
  11. Wanxing Duan · 5 shared papers, 2015–2016 · strength 0.23
  12. Zhenhua Ma · 5 shared papers, 2013–2016 · strength 0.22
  13. Zhengdong Jiang · 4 shared papers, 2015–2016 · strength 0.21
  14. Wěi Li · 2 shared papers, 2013–2022 · strength 0.19
  15. Weili Min · 1 shared paper, 2022 · strength 0.16
  16. Xin Zhang · 1 shared paper, 2022 · strength 0.16
  17. Wunai Zhang · 1 shared paper, 2022 · strength 0.16
  18. Tao Shan · 3 shared papers, 2016 · strength 0.15
  19. Jiguang Ma · 3 shared papers, 2015–2016 · strength 0.13
  20. Jiahui Li · 2 shared papers, 2016 · strength 0.10
  21. Ligang Nan · 2 shared papers, 2015–2016 · strength 0.10
  22. Zheng Wu · 2 shared papers, 2015–2016 · strength 0.09
  23. Liang Han · 2 shared papers, 2015–2016 · strength 0.09
  24. Erxi Wu · 2 shared papers, 2015–2016 · strength 0.09
  25. Zheng Wang · 2 shared papers, 2015 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.